Project Grant R43NS137898
Award Date
9/19/24
Completion Date
8/31/25
Dollars Obligated
$1M
Federal Agency
National Institute of Neurological Disorders and Stroke
Awardee
Renerva LLC (LJ97PLMMTGV1)
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Carson, PA 15203, USA
Similar Awards
Renerva LLC, a for-profit manufacturer, is developing peripheral nerve matrix (PNM) technologies to facilitate functional recovery in animal models of direct muscle neurotization (DMN) through a $494,955 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). The two-year project aims to 1) optimize the formulation of a clinical-grade PNM product to provide...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $296,151 to Insoma Bio, Inc. to investigate the use of their proprietary Fractomer biomaterial to improve outcomes after peripheral nerve repair. The project aims to demonstrate that Fractomer, an injectable polypeptide scaffold, can provide the necessary mechanical support and...
The University of Nebraska Medical Center (UNMC) was awarded a $437,331 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant will support the development of a novel "optoelectronically active nerve adhesive" to accelerate peripheral nerve repair and regeneration. Specifically, the project aims to incorporate innovative...
This Project Grant award of $1,214,399 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will fund the development of a novel minimally invasive electrode strategy to better target the posterior tibial nerve for the treatment of overactive bladder (OAB). The University of Wisconsin System is the prime awardee, with subawards to Neuronoff Inc. for device fabrication and Case...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under CFDA Program 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders, is focused on developing a noninvasive, nanoparticle-directed therapy to deliver treatments to the peripheral nervous system. The $310,834 award to Clemson University supports research to design and implement a nerve-targeting polymersome platform that can penetrate the blood-nerve barrier and...
This Project Grant awarded by the National Science Foundation (CFDA 47.041 - Engineering) to Cleveland State University (CSU) provides $500,000 in funding from January 1, 2025 to December 31, 2027 to develop bioprinted tissue scaffolds with Schwann cell density gradients and electrical conductivity for peripheral nerve regeneration. The goal is to understand how Schwann cell density gradients and electrical properties within the scaffolds can enhance the regeneration of injured peripheral...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under CFDA 93.853 "Extramural Research Programs in the Neurosciences and Neurological Disorders", provides $594,115.00 to the University of Utah to conduct research on the pathophysiology of peripheral nerve regeneration and the formation of neuromas. The key objectives of this 5-year project are to: 1) analyze the cellular composition, activation states, and spatial niches involved in...
This $210,600 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will fund research to investigate how Wnt signaling mediates the formation of repair cells from Schwann cells in the peripheral nervous system. The primary goals are to 1) provide functional tests of the role of Wnt receptors and ligands in controlling repair cell...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is focused on developing a novel drug candidate to treat demyelinating neuropathies. The $352,073 award will support rigorous in vivo testing of the experimental ABCA1 agonist drug, CS6253, in validated mouse models of hereditary peripheral nerve disorders characterized by impaired...
The National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $970,052 Project Grant to Backstop Neural, Inc. on Aug 20, 2024. The goal of this Phase I SBIR project is to demonstrate the feasibility of a novel, thin and softening epidural stimulation lead to treat chronic arm and neck pain. The key products to be delivered include: 1) Design and fabrication of a 16-channel, 0.2 mm thick human-sized softening...